口腔扁平上皮癌患者における扁平上皮癌関連抗原 Squamous Cell Carcinoma Related Antigen の臨床的研究
スポンサーリンク
概要
- 論文の詳細を見る
There has been a large number of reports on the clinical usefulness of tumor markers for various malignant tumors in many medical fields, and these tumor markers are known as tumor-mediated substances but are not known as specific substances directly produced by a tumor tissue itself. Since no materials biosynthesized specifically by tumor cells have yet been discovered, tumor-associated substances have been applied widely and clinically as tumor markers for determination of clinical diagnosis and effect of treatment and monitoring progress and prognosis. Squamous cell carcinoma related antigen (SCC) was originally purified from squamous cell carcinoma tissues of uterine cervix by Dr. Kato. Among various tumor markers, it has been known to appear with high positive rates not only in patients with uterine cancer but also in those with malignant tumor in another organ. Clinical utility of this fact has been attracting attention. Fifty patients with squamous cell carcinoma in the oral cavity were therefore examined for serum SCC level and clinical evaluation was made. The serum levels of SCC-antigen were measured with an SCC-RIA (Dainabot) kit. The results were as follows : 1. The average serum SCC of 50 patients with oral cancer (squamous cell carcinoma) was 2.22±2.11 ng/ml and the positive rate was 42.0% (21/50 cases). In contrast, the average for control patients with benign oral disease was 1.46±0.47 ng/ml and the positive rate was 8.3% (1/12 cases). Statistically significant difference was found. 2. In serum SCC levels, gingival cancer of upper and lower jaws were at higher levels than another oral cancer. 3. With progress of clinical stage, namely, as the tumor grew and the lesion developed, serum SCC level gradually increased its average and positive rate. Also, in comparison with primary cancer, advanced cancer showed higher values in many cases. 4. By prognosis, the average of SCC level and positive rate for good prognosis cases were 1.54±0.73 ng/ml and 38.1% (8/21 cases), respectively. For poor prognosis cases, they were 2.71±2.60 ng/ml and 44.8% (13/29 cases). 5. As to change in serum SCC level before and after treatment, serum SCC level tended to decrease and become negative after treatment for the cases of good prognosis. For the cases of poor prognosis, serum SCC level was unchanged or increased in many cases and tended to become negative. With imminent death especially, serum SCC level was markedly high. 6. In these investigations, serum SCC level is thought to be a useful indicator for estimating progress, effect of treatment, and prognosis. Its clinical utility is considerable.
- 九州歯科学会の論文
- 1991-10-25
著者
関連論文
- 下顎骨に発現した骨肉腫の 1 症例
- 14 年後に再発したエナメル上皮腫の 1 例
- 口腔領域悪性腫瘍に関する臨床的検討 : 舌癌症例について
- 23. 口腔領域悪性腫瘍患者における腫瘍マーカーについての検索(第 47 回九州歯科学会総会講演抄録)
- 23∿1120 口腔領域悪性腫瘍患者における腫瘍マーカーについての検索
- 下唇に発現した脂肪腫の 2 症例
- 口腔扁平上皮癌患者における扁平上皮癌関連抗原 Squamous Cell Carcinoma Related Antigen の臨床的研究 : 主論文の要旨
- 口腔扁平上皮癌患者における扁平上皮癌関連抗原 Squamous Cell Carcinoma Related Antigen の臨床的研究
- Acanthosis nigricansの1例
- 口腔領域における類表皮嚢胞の1例
- 口腔領域悪性腫瘍患者における腫瘍マーカーについての検討